Cite
HARVARD Citation
Funke, A. et al. (n.d.). P40. Delta-9-Tetrahydrocannabinol-cannabidiol (THC/CBD) oromucosal spray for the treatment of spasticity in ALS – Assessment of patient reported outcomes. Clinical neurophysiology. 129 (8), pp. e83-. [Online].